Shares of Johnson & Johnson, which rose till 1.44% over the past week, on Tuesday closed with a decrease of 2.3%, despite on the publication of a better-than-expected Wall Street experts, a report for 3 fin. quarter. Investors are concerned about the potential consequences of ending the large-scale study of the J&J vaccine against COVID-19, […]
Shares of the Johnson & Johnson may slow because the last stimulus to it was the company’s transition to the final clinical trial of the vaccine against COVID-19 on September 23, after which the shares rose by more than 5%. However, as of Tuesday, before the opening of trading, the price of J&J shares did […]
Shares of Johnson & Johnson rose by 0.68% on Thursday, ahead of the growth of the S&P 500 index by 0.32% after as the company announced that it plans to begin the final phase of a clinical trial of its COVID-19 vaccine in September. Shares of J&J recovered after losses in February and March and […]
Johnson & Johnson was one of the first companies to devote large resources to the fight against COVID-19 and vaccine development, and was one of the first to receive support from the US government. However, J&J is not currently one of the companies, who conducting clinical trials of its final vaccine candidates COVID-19 in humans. […]